Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Taiho Pharmaceutical To Launch Generic Campto

This article was originally published in PharmAsia News

Executive Summary

Tokyo based drug maker Taiho Pharmaceutical will launch anticancer drug irinotecanin May. The injection products will come in 40 milligram and 100 milligram doses. The company obtained manufacturing and marketing approval Jan. 28. Taiho has set its oncology business as top propriety; however, generic drugs are the first in its oncology lineup. With hospitals increased use of diagnostic procedure combined payment systems, the company sees a strong demand for generic cancer drugs. (Click here for more - Japanese language
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC070896

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel